INSM compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

INSMInsmed Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

INSMInsmed Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INSM2 of 4 reports

2 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.7%▲+15.06%×1.03

Q2 FY26±11.7%▲+33.86%×2.90

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedINSM realized, solidLLY realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedspan: INSM 84d · LLY 267dSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

INSMInsmed Inc

109.32· pre 108.08· delayed

Mkt cap$24.7BRevenue$524MQ3 FY26Revenue$606MFY25

LLYELI Lilly & Co

1,418.01· pre 1,398.98· delayed

Pre-marketNov 3 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 3 '26delayed

INSMInsmed Inc

LLYELI Lilly & Co

109.32pre 108.08delayed

Price

1,418.01pre 1,398.98delayed

$24.7B

Mkt cap

$1.3T

Q3 FY26$524M

Revenue

$24.4BQ3 FY26

FY25$606M

Revenue

$65.2BFY25

INSM109.32vsLLY1,418.01Pre-marketNov 3 '26delayed